High prevalence and poor linkage to care of transfusion-transmitted infections among blood donors in Dar-es-Salaam, Tanzania.


Journal

Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672

Informations de publication

Date de publication:
06 2019
Historique:
received: 23 09 2018
accepted: 05 01 2019
pubmed: 4 2 2019
medline: 23 7 2020
entrez: 4 2 2019
Statut: ppublish

Résumé

Blood transfusion is one of the most commonly relied upon therapies in sub-Saharan Africa. Existing safeguards recommended include systematic screening for transfusion-transmitted infections and restricted voluntary nonremunerated blood donor selection. We report the transfusion-transmitted infection screening and notification practice at a large urban blood transfusion centre in Dar-es-Salaam, Tanzania. Between October 2016 and March 2017 anonymized records of all donors registered at the blood transfusion unit were accessed to retrospectively note demographic information, donor status, first-time status, transfusion-transmitted infection result and notification. 6402 consecutive donors were screened for transfusion-transmitted infections; the majority were family/replacement blood donors (88.0%) and male (83.8%). Overall transfusion-transmitted infections prevalence was 8.4% (95% CI 7.8-9.1), with hepatitis B being the most prevalent infection (4.1% (95% CI 3.6-4.6)). Transfusion-transmitted infections were more common in family/replacement blood donors (9.0% (95% CI 8.3-9.8)) as compared to voluntary nonremunerated blood donor (4.1% (95% CI 2.8-5.7)). A minority of infected-donors were notified of a positive result (8.5% (95% CI 6.3-11.2)). Although transfusion-transmitted infections are more prevalent among family/replacement blood donors, overall risk of transfusion-transmitted infections across all groups is considerable. In addition, existing efforts to notify donors of a positive transfusion-transmitted infection are poor. Future policies must focus on improving linkage to care for newly diagnosed patients with transfusion-transmitted infections.

Identifiants

pubmed: 30712273
doi: 10.1111/jvh.13073
pmc: PMC6563112
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

750-756

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. Journal of Viral Hepatitis Published by John Wiley & Sons Ltd.

Références

J Clin Microbiol. 2015 Apr;53(4):1156-63
pubmed: 25631805
J Viral Hepat. 2018 Dec;25(12):1438-1445
pubmed: 29974582
Am J Trop Med Hyg. 2016 Dec 7;95(6):1368-1375
pubmed: 27928086
Transfus Med Rev. 2012 Apr;26(2):164-80
pubmed: 21872426
Transfusion. 2009 Apr;49(4):669-75
pubmed: 19170991
Transfus Med. 2010 Feb;20(1):1-10
pubmed: 19725906
Lancet Glob Health. 2017 Feb;5(2):e131-e132
pubmed: 28104174
J Viral Hepat. 2019 Jun;26(6):750-756
pubmed: 30712273
Vaccine. 1990 Mar;8 Suppl:S18-20; discussion S21-3
pubmed: 2139281
Br J Haematol. 2011 Sep;154(6):763-9
pubmed: 21539535
Transfus Med. 2007 Dec;17(6):434-42
pubmed: 18067647
Transfusion. 2010 Feb;50(2):340-3
pubmed: 19843284
J Clin Pathol. 2007 Oct;60(10):1117-20
pubmed: 17412875
Lancet Glob Health. 2016 Aug;4(8):e559-67
pubmed: 27443781
Transfusion. 2005 Feb;45(2):133-40
pubmed: 15660820

Auteurs

Zameer Mohamed (Z)

Department of Hepatology, Imperial College London, St Mary's Hospital, London, UK.

Jin U Kim (JU)

Department of Hepatology, Imperial College London, St Mary's Hospital, London, UK.

Alex Magesa (A)

Department of Biochemistry and Haematology, Muhimbili National Hospital, Dar es Salaam, Tanzania.

Mabula Kasubi (M)

Department of Biochemistry and Haematology, Muhimbili National Hospital, Dar es Salaam, Tanzania.

Sarah F Feldman (SF)

Unité d'Épidémiologie des Maladies Émergentes, Institut Pasteur, Paris, France.

Stephane Chevaliez (S)

French National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Université Paris-Est, Créteil, France.

Promise Mwakale (P)

Department of Bioethics, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Simon D Taylor-Robinson (SD)

Department of Hepatology, Imperial College London, St Mary's Hospital, London, UK.

Mark R Thursz (MR)

Department of Hepatology, Imperial College London, St Mary's Hospital, London, UK.

Yusuke Shimakawa (Y)

Unité d'Épidémiologie des Maladies Émergentes, Institut Pasteur, Paris, France.

John Rwegasha (J)

Department of Gastroenterology, Muhimbili National Hospital, Dar es Salaam, Tanzania.

Maud Lemoine (M)

Department of Hepatology, Imperial College London, St Mary's Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH